Related Experiment Video
Updated: Feb 25, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Candida auris: a worrisome, globally emerging pathogen
Bhagyashri D Navalkele1, Sanjay Revankar2, Pranatharthi Chandrasekar3
1a Infection Prevention and Antimicrobial Stewardship Fellow, Division of Infectious Diseases , Wayne State University/Detroit Medical Center , Detroit , MI , USA.
Introduction:
Candida auris is a recently discovered, rapidly emerging fungal pathogen. Infections due to C. auris are hospital-acquired, multidrug resistant and associated with high mortality. Areas covered: This review highlights epidemiology, pathogenesis, microbiological characteristics, clinical presentation, diagnostic challenges and treatment options of C. auris infections. Infection prevention measures to prevent spread of C. auris and special measures during an outbreak situation have also been reviewed. Expert commentary: Rapid emergence of hospital onset C. auris is worrisome. Early diagnosis of C. auris is essential for better outcomes and the implementation of infection prevention measures. Lack of widespread awareness, absence of general availability of diagnostic testing methods, and limited options for treatment of C. auris infections make it a difficult-to-treat pathogen. Further studies are needed for better understanding of this emerging pathogen.
Insights
Candida auris is a challenging, multidrug-resistant fungal pathogen causing hospital-acquired infections with high mortality. Early diagnosis and infection control are crucial for managing this emerging threat.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Hospital Epidemiology
Background:
- Candida auris is a novel fungal pathogen causing serious hospital-acquired infections.
- These infections are characterized by multidrug resistance and high mortality rates.
- The rapid emergence of Candida auris presents a significant global health concern.
Purpose of the Study:
- To review the epidemiology, pathogenesis, and clinical presentation of Candida auris infections.
- To discuss diagnostic challenges and current treatment strategies.
- To highlight infection prevention and outbreak management measures.
Main Methods:
- Literature review of epidemiology, pathogenesis, clinical presentation, diagnostics, and treatment.
- Analysis of infection prevention and outbreak control strategies.
- Expert commentary on the challenges posed by Candida auris.
Main Results:
- Candida auris infections are hospital-acquired, multidrug-resistant, and have high mortality.
- Early diagnosis and effective infection prevention are critical for patient outcomes.
- Limited diagnostic availability and treatment options complicate management.
Conclusions:
- The rapid emergence of hospital-onset Candida auris is a major concern.
- Improved diagnostic methods and treatment options are urgently needed.
- Further research is essential to understand and combat this difficult-to-treat pathogen.
Related Concept Videos
Fungal Phylum Ascomycota
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Fungal Phylum Microsporidia
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

